Investindustrial takes majority stake in Lifebrain

ITALY Health Providers / Healthcare Facilities / Labs (Biology) REV €50–100M

Context

Investindustrial acquired a controlling stake in Lifebrain from the investment vehicle lb EK Management. The deal follows a period of intense growth supported by MCI Capital, during which the group established itself as a leading consolidator in the fragmented Italian laboratory market. The acquisition was structured through a Luxembourg vehicle, European Laboratory Services, and aimed to provide the capital and expertise necessary to professionalize the group and accelerate its aggressive acquisition strategy across Italy.

Lifebrain, which reported an EBITDA margin of [members only] in 2016, is valued in this transaction at an EV/EBITDA multiple of [members only].

-> Deep-dive in Healthcare & Pharma market trends

Target

Lifebrain is Italy's largest provider of clinical laboratory testing services. The group operates a vast network of approximately 360 sites across the country and generates over EUR200 million in revenue. Beyond its core medical diagnostics business, Lifebrain has successfully diversified into environmental and food safety testing markets. Under its previous ownership, the company became a prolific consolidator, completing 70 acquisitions in just three years to achieve its current scale.

Ent. Value

[members only]

Equity Value

[members only]

Multiples

EV / Revenue

[members only]

EV / EBITDA

[members only]

EV / EBIT

[members only]

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2016

2015

Other operations with Lifebrain

Other operations with Lifebrain
Date	Acquirer	Target	Country	Sector
07/2021	CERBA HEALTHCARE	LIFEBRAIN	ITALY	Labs (Biology)

Other operations with Investindustrial

Other operations with Investindustrial
Date	Acquirer	Target	Country	Sector
06/2026	INVESTINDUSTRIAL	ARTSANA	ITALY	Personal & Household
07/2024	INVESTINDUSTRIAL	PIOVANGROUP	ITALY	Robotics & Automation
02/2024	INVESTINDUSTRIAL / SAMMONTANA	FORNO D’ASOLO	ITALY	Bakery / Pastry
06/2021	INVESTINDUSTRIAL	TARGA TELEMATICS	ITALY	Automotive
07/2019	INVESTINDUSTRIAL	NATRA	SPAIN	Food Products
04/2017	INVESTINDUSTRIAL	ARTSANA	ITALY	Personal & Household

Similar deals in Health Providers

Similar deals in Health Providers
Date	Acquirer	Target	Country	Sector
01/2019	HUMANA	CORONARIA HOIVA	FINLAND	Nursing Homes
11/2018	DENTALPRO	CLINIODENT	SWITZERLAND	Dental Centers
03/2018	THE ADOLFSEN GROUP	FRÖSUNDA	SWEDEN	Healthcare Facilities
03/2018	ICV PARTNERS	OUTPATIENT IMAGING AFFILIATES	UNITED STATES	Radiology
01/2018	PERMIRA	I-MED RADIOLOGY NETWORK	AUSTRALIA	Radiology
06/2017	ICG / MANAGEMENT & PRIVATE INVESTORS	DOMUSVI	FRANCE	Nursing Homes
05/2017	BC PARTNERS	DENTALPRO	ITALY	Dental Centers
04/2017	EQT PARTNERS	COLISÉE	FRANCE	Nursing Homes
01/2017	PARTNERS GROUP / PSP INVESTMENTS	CERBA HEALTHCARE	FRANCE	Labs (Biology)
01/2017	MARS	VCA	UNITED STATES	Vet Clinics

REFERENCES

Revenue range: REV €50–100M

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of Lifebrain by Investindustrial are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

FAQ

What transaction does this page cover?

This page covers the acquisition of a majority stake in Lifebrain, an Italian company specialised in Healthcare Facilities, by Investindustrial in 2018. Ownership has since evolved, leading to a subsequent transaction with Cerba Healthcare in July 2021 (see the dedicated deal page for details).

What was Lifebrain’s revenue at the time of the deal?

At the time of the transaction, Lifebrain’s annual revenue was estimated within the €50–100M range (FY 2016). Detailed financial figures are available to members.

What sources support the information on this transaction?

Transaction data and operational intelligence were compiled from independent financial press reporting by specialized M&A publications.

What is mynth?

mynth is the first free M&A database dedicated to Small & Mid-Cap transactions. We centralize Enterprise Values, revenue multiples, EBITDA multiples and transaction financials that are typically locked behind five-figure subscriptions on platforms like Capital IQ or Mergermarket. On mynth, searching and browsing deals is completely free. Our mission is simple: make professional-grade valuation intelligence accessible to every M&A advisor, independent consultant, Private Equity professional and student, without the burden of expensive annual licenses.